Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
4 pending office actions • 1 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Sookmyung Women'S University Industry-Academic Cooperation Foundation currently has 4 pending office actions in the Chemistry & Materials technology area. These 4 actions are distributed across distinct examiners, meaning each examiner is handling an individual matter. However, all the pending office actions are situated within 1 distinct art unit. This creates a situation where multiple examiners are working within the same technical group on the university's applications.
The busiest examiner, LI, TRACY Y, is responsible for 1 busiest examiner pending action. This distribution shows that while the university is dealing with multiple examiners, the examination is technically centralized within the art unit. This structure suggests that the pending office actions involve related subject matter within the Chemistry & Materials field. For a practitioner, the presence of various examiners in 1 distinct art unit may lead to different examination outcomes for similar technologies.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §103 only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LI, TRACY Y | 1 | 80.6% | +16.1% |
| ALAM, AYAAN A | 1 | 38.4% | +35.6% |
| ROZOF, TIMOTHY R | 1 | 72.7% | +23.6% |
| TRINH, THANH TRUC | 1 | 22.1% | +10.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18959774 | PARAMETER DETERMINATION SYSTEM AND PARAMETER DETERMINATION METHOD THEREOF | LI, TRACY Y | — |
| 18951216 | Composition for Neuroprotection, Containing Plant Extract or Fraction as Active Ingredient | ALAM, AYAAN A | — |
| 18847251 | NOVEL HETEROCYCLIC INHIBITOR FOR HISTONE DEACETYLASE, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | ROZOF, TIMOTHY R | — |
| 18708088 | ELECTRODE OF DYE-SENSITIZED SOLAR CELL AND METHOD FOR MANUFACTURING THE SAME | TRINH, THANH TRUC | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18959774 | PARAMETER DETERMINATION SYSTEM AND PARAMETER DETERMINATION METHOD THEREOF | LI, TRACY Y | — |
| 18951216 | Composition for Neuroprotection, Containing Plant Extract or Fraction as Active Ingredient | ALAM, AYAAN A | — |
| 18847251 | NOVEL HETEROCYCLIC INHIBITOR FOR HISTONE DEACETYLASE, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | ROZOF, TIMOTHY R | — |
| 18708088 | ELECTRODE OF DYE-SENSITIZED SOLAR CELL AND METHOD FOR MANUFACTURING THE SAME | TRINH, THANH TRUC | — |
| Art Unit | Apps |
|---|---|
| 1726 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18959774 | PARAMETER DETERMINATION SYSTEM AND PARAMETER DETERMINATION METHOD THEREOF | LI, TRACY Y | — | §103§112 | Non-Final OA | — | Pending | Nov 26, 2024 |
| 18951216 | Composition for Neuroprotection, Containing Plant Extract or Fraction as Active Ingredient | ALAM, AYAAN A | — | §101§102§112 | Non-Final OA | — | Pending | Nov 18, 2024 |
| 18847251 | NOVEL HETEROCYCLIC INHIBITOR FOR HISTONE DEACETYLASE, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | ROZOF, TIMOTHY R | — | §102§112 | Non-Final OA | — | Pending | Sep 15, 2024 |
| 18708088 | ELECTRODE OF DYE-SENSITIZED SOLAR CELL AND METHOD FOR MANUFACTURING THE SAME | TRINH, THANH TRUC | 1726 | §103 | Non-Final OA | — | Pending | May 07, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial